US Stock MarketDetailed Quotes

TBPH Theravance Biopharma

Watchlist
  • 8.100
  • -0.110-1.34%
Close Oct 3 16:00 ET
396.27MMarket Cap-8526P/E (TTM)

Theravance Biopharma Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
64.50%-4.42M
90.89%-1.02M
-1,013.28%-27M
-101.56%-854K
85.31%-2.49M
9.40%-12.44M
57.95%-11.22M
98.97%-2.43M
221.35%54.91M
76.00%-16.93M
Net income from continuing operations
-5.65%-16.53M
47.19%-11.66M
40.54%-55.19M
40.31%-8.51M
42.32%-8.95M
31.36%-15.65M
45.14%-22.09M
64.98%-92.82M
75.34%-14.26M
79.36%-15.52M
Operating gains losses
----
----
326.50%1.35M
-101.14%-1K
-99.97%1K
150.77%1.32M
113.74%29K
712.82%317K
--88K
--3.05M
Depreciation and amortization
5.95%979K
20.55%1.18M
-39.41%4.26M
-30.02%1.42M
-46.97%937K
-51.60%924K
-26.08%978K
-18.31%7.02M
58.20%2.03M
-32.27%1.77M
Deferred tax
---561K
---513K
--3.21M
----
----
--0
--0
--0
----
----
Other non cash items
13.38%644K
14.36%629K
141.27%2.35M
13.27%623K
29.30%609K
129.65%568K
-70.57%550K
152.56%974K
2,300.00%550K
128.37%471K
Change In working capital
145.86%2.69M
79.90%4.12M
-119.69%-8.34M
-105.73%-3.41M
91.17%-1.35M
-397.82%-5.87M
157.93%2.29M
207.08%42.35M
1,154.65%59.56M
-97.54%-15.23M
-Change in receivables
110.35%365K
-37.76%2.81M
74.67%-689K
84.39%-417K
22.45%-1.26M
-1,571.09%-3.53M
152.52%4.52M
-250.86%-2.72M
-4,073.44%-2.67M
8.70%-1.63M
-Change in prepaid assets
176.21%724K
187.18%3.99M
-155.39%-4.45M
-290.93%-3.01M
54.30%-1.87M
-136.34%-950K
-82.52%1.39M
-38.22%8.03M
-73.55%1.58M
-189.84%-4.1M
-Change in payables and accrued expense
136.52%1.14M
3.69%-3.21M
58.16%-7.09M
-227.39%-786K
102.31%148K
-488.53%-3.12M
72.12%-3.34M
58.43%-16.94M
109.65%617K
-23.22%-6.4M
-Change in other current assets
-150.67%-226K
-102.58%-30K
81.19%-1.55M
-20.20%-4.68M
202.21%1.53M
115.73%446K
116,000.00%1.16M
-746.30%-8.23M
-11,558.82%-3.9M
25.31%-1.5M
-Change in other current liabilities
-196.96%-1.24M
15.13%-1.22M
393.48%4.55M
27,041.18%4.58M
107.45%119K
-27.71%1.28M
15.99%-1.43M
-60.52%-1.55M
99.22%-17K
-220.04%-1.6M
-Change in other working capital
38,760.00%1.93M
29,783.33%1.78M
-98.61%886K
-98.59%903K
0.00%-6K
97.08%-5K
33.33%-6K
647.20%63.76M
2,228.70%63.95M
99.79%-6K
Cash from discontinued investing activities
0
0
-761.12%-184.57M
-6,455.40%-178.97M
-5.21M
Operating cash flow
64.50%-4.42M
90.89%-1.02M
85.56%-27M
99.31%-854K
88.77%-2.49M
15.57%-12.44M
56.96%-11.22M
10.04%-186.99M
-192.35%-124.06M
51.29%-22.14M
Investing cash flow
Cash flow from continuing investing activities
-127.44%-3.03M
139.56%17.03M
-155.54%-32.7M
-101.73%-677K
99.89%-21K
47.00%11.05M
-234.84%-43.05M
-52.71%58.88M
261.80%39.16M
44.89%-19.73M
Net PPE purchase and sale
-107.98%-36K
87.50%-91K
-175.35%-975K
-154.51%-677K
-136.84%-21K
569.79%451K
-145.53%-728K
138.06%1.29M
40.09%-266K
105.52%57K
Net investment purchase and sale
-128.27%-3M
140.45%17.12M
-157.81%-31.72M
--0
--0
39.22%10.6M
-239.55%-42.32M
-57.10%54.87M
249.90%39.43M
35.30%-22.49M
Net other investing changes
----
----
----
----
----
----
----
--2.71M
--0
----
Cash from discontinued investing activities
Investing cash flow
-127.44%-3.03M
139.56%17.03M
-102.83%-32.7M
-101.73%-677K
-100.00%-21K
47.00%11.05M
-234.84%-43.05M
826.96%1.15B
261.80%39.16M
3,104.52%1.08B
Financing cash flow
Cash flow from continuing financing activities
99.95%-44K
96.95%-1.72M
73.07%-198.93M
13.71%-30.61M
95.53%-31.4M
-57,728.57%-80.68M
-3,783.98%-56.24M
-904.07%-738.62M
-23,906.71%-35.47M
-30,601.53%-701.84M
Net issuance payments of debt
----
----
--0
--0
----
----
----
-5,786.33%-631.6M
--0
----
Net common stock issuance
99.48%-419K
96.95%-1.72M
-50.86%-199.55M
13.98%-30.78M
66.84%-31.4M
-23,279.25%-81.13M
-3,783.98%-56.24M
-233.46%-132.28M
-7,765.05%-35.79M
-4,042.56%-94.7M
Proceeds from stock option exercised by employees
----
----
-22.94%618K
-44.90%173K
-200.00%-1K
----
----
-76.89%802K
-48.01%314K
--1K
Net other financing activities
----
----
----
----
----
----
----
--24.46M
--0
----
Cash from discontinued financing activities
0
0
-20.19M
0
-20.19M
Financing cash flow
99.95%-44K
96.95%-1.72M
73.78%-198.93M
13.71%-30.61M
95.65%-31.4M
-57,728.57%-80.68M
-3,783.98%-56.24M
-926.05%-758.81M
-23,906.71%-35.47M
-31,484.69%-722.03M
Net cash flow
Beginning cash position
-71.00%54.67M
-86.50%40.38M
229.32%299.01M
-82.71%72.52M
20.77%106.43M
98.00%188.5M
229.32%299.01M
10.32%90.8M
243.03%419.37M
-57.17%88.13M
Current changes in cash
90.87%-7.49M
112.93%14.29M
-224.21%-258.63M
73.30%-32.14M
-110.24%-33.91M
-1,059.99%-82.07M
-2,607.53%-110.51M
2,350.71%208.21M
-282.59%-120.37M
496.58%331.25M
End cash Position
-55.67%47.18M
-71.00%54.67M
-86.50%40.38M
-86.50%40.38M
-82.71%72.52M
20.77%106.43M
98.00%188.5M
229.32%299.01M
229.32%299.01M
243.03%419.37M
Free cash flow
66.50%-4.45M
90.85%-1.11M
84.28%-29.49M
98.77%-1.53M
88.65%-2.51M
10.48%-13.29M
53.80%-12.16M
11.22%-187.56M
-189.94%-124.32M
52.50%-22.08M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
--
--
--
(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 64.50%-4.42M90.89%-1.02M-1,013.28%-27M-101.56%-854K85.31%-2.49M9.40%-12.44M57.95%-11.22M98.97%-2.43M221.35%54.91M76.00%-16.93M
Net income from continuing operations -5.65%-16.53M47.19%-11.66M40.54%-55.19M40.31%-8.51M42.32%-8.95M31.36%-15.65M45.14%-22.09M64.98%-92.82M75.34%-14.26M79.36%-15.52M
Operating gains losses --------326.50%1.35M-101.14%-1K-99.97%1K150.77%1.32M113.74%29K712.82%317K--88K--3.05M
Depreciation and amortization 5.95%979K20.55%1.18M-39.41%4.26M-30.02%1.42M-46.97%937K-51.60%924K-26.08%978K-18.31%7.02M58.20%2.03M-32.27%1.77M
Deferred tax ---561K---513K--3.21M----------0--0--0--------
Other non cash items 13.38%644K14.36%629K141.27%2.35M13.27%623K29.30%609K129.65%568K-70.57%550K152.56%974K2,300.00%550K128.37%471K
Change In working capital 145.86%2.69M79.90%4.12M-119.69%-8.34M-105.73%-3.41M91.17%-1.35M-397.82%-5.87M157.93%2.29M207.08%42.35M1,154.65%59.56M-97.54%-15.23M
-Change in receivables 110.35%365K-37.76%2.81M74.67%-689K84.39%-417K22.45%-1.26M-1,571.09%-3.53M152.52%4.52M-250.86%-2.72M-4,073.44%-2.67M8.70%-1.63M
-Change in prepaid assets 176.21%724K187.18%3.99M-155.39%-4.45M-290.93%-3.01M54.30%-1.87M-136.34%-950K-82.52%1.39M-38.22%8.03M-73.55%1.58M-189.84%-4.1M
-Change in payables and accrued expense 136.52%1.14M3.69%-3.21M58.16%-7.09M-227.39%-786K102.31%148K-488.53%-3.12M72.12%-3.34M58.43%-16.94M109.65%617K-23.22%-6.4M
-Change in other current assets -150.67%-226K-102.58%-30K81.19%-1.55M-20.20%-4.68M202.21%1.53M115.73%446K116,000.00%1.16M-746.30%-8.23M-11,558.82%-3.9M25.31%-1.5M
-Change in other current liabilities -196.96%-1.24M15.13%-1.22M393.48%4.55M27,041.18%4.58M107.45%119K-27.71%1.28M15.99%-1.43M-60.52%-1.55M99.22%-17K-220.04%-1.6M
-Change in other working capital 38,760.00%1.93M29,783.33%1.78M-98.61%886K-98.59%903K0.00%-6K97.08%-5K33.33%-6K647.20%63.76M2,228.70%63.95M99.79%-6K
Cash from discontinued investing activities 00-761.12%-184.57M-6,455.40%-178.97M-5.21M
Operating cash flow 64.50%-4.42M90.89%-1.02M85.56%-27M99.31%-854K88.77%-2.49M15.57%-12.44M56.96%-11.22M10.04%-186.99M-192.35%-124.06M51.29%-22.14M
Investing cash flow
Cash flow from continuing investing activities -127.44%-3.03M139.56%17.03M-155.54%-32.7M-101.73%-677K99.89%-21K47.00%11.05M-234.84%-43.05M-52.71%58.88M261.80%39.16M44.89%-19.73M
Net PPE purchase and sale -107.98%-36K87.50%-91K-175.35%-975K-154.51%-677K-136.84%-21K569.79%451K-145.53%-728K138.06%1.29M40.09%-266K105.52%57K
Net investment purchase and sale -128.27%-3M140.45%17.12M-157.81%-31.72M--0--039.22%10.6M-239.55%-42.32M-57.10%54.87M249.90%39.43M35.30%-22.49M
Net other investing changes ------------------------------2.71M--0----
Cash from discontinued investing activities
Investing cash flow -127.44%-3.03M139.56%17.03M-102.83%-32.7M-101.73%-677K-100.00%-21K47.00%11.05M-234.84%-43.05M826.96%1.15B261.80%39.16M3,104.52%1.08B
Financing cash flow
Cash flow from continuing financing activities 99.95%-44K96.95%-1.72M73.07%-198.93M13.71%-30.61M95.53%-31.4M-57,728.57%-80.68M-3,783.98%-56.24M-904.07%-738.62M-23,906.71%-35.47M-30,601.53%-701.84M
Net issuance payments of debt ----------0--0-------------5,786.33%-631.6M--0----
Net common stock issuance 99.48%-419K96.95%-1.72M-50.86%-199.55M13.98%-30.78M66.84%-31.4M-23,279.25%-81.13M-3,783.98%-56.24M-233.46%-132.28M-7,765.05%-35.79M-4,042.56%-94.7M
Proceeds from stock option exercised by employees ---------22.94%618K-44.90%173K-200.00%-1K---------76.89%802K-48.01%314K--1K
Net other financing activities ------------------------------24.46M--0----
Cash from discontinued financing activities 00-20.19M0-20.19M
Financing cash flow 99.95%-44K96.95%-1.72M73.78%-198.93M13.71%-30.61M95.65%-31.4M-57,728.57%-80.68M-3,783.98%-56.24M-926.05%-758.81M-23,906.71%-35.47M-31,484.69%-722.03M
Net cash flow
Beginning cash position -71.00%54.67M-86.50%40.38M229.32%299.01M-82.71%72.52M20.77%106.43M98.00%188.5M229.32%299.01M10.32%90.8M243.03%419.37M-57.17%88.13M
Current changes in cash 90.87%-7.49M112.93%14.29M-224.21%-258.63M73.30%-32.14M-110.24%-33.91M-1,059.99%-82.07M-2,607.53%-110.51M2,350.71%208.21M-282.59%-120.37M496.58%331.25M
End cash Position -55.67%47.18M-71.00%54.67M-86.50%40.38M-86.50%40.38M-82.71%72.52M20.77%106.43M98.00%188.5M229.32%299.01M229.32%299.01M243.03%419.37M
Free cash flow 66.50%-4.45M90.85%-1.11M84.28%-29.49M98.77%-1.53M88.65%-2.51M10.48%-13.29M53.80%-12.16M11.22%-187.56M-189.94%-124.32M52.50%-22.08M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ----Unqualified Opinion with Explanatory Notes--------------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data